CORC

在结果中检索

CORC

浏览/检索结果: 共20条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression 期刊论文
2019, 卷号: 145, 期号: 6, 页码: 1569-1579
作者:  Schuler, Martin;  Tan, Eng-Huat;  O'Byrne, Kenneth;  Zhang, Li;  Boyer, Michael
收藏  |  浏览/下载：20/0  |  提交时间：2020/01/03
The 102 Landslide: human-slope interaction in SE Tibet over a 20-year period 期刊论文
ENVIRONMENTAL EARTH SCIENCES, 2017, 卷号: 76, 期号: 1
作者:  Shang, Yanjun;  Hyun, Chang-Uk;  Park, Hyeong-Dong;  Yang, Zhifa;  Yuan, Guangxiang
收藏  |  浏览/下载：23/0  |  提交时间：2017/11/17
First-Line Afatinib versus Gefitinib in EGFRm plus Advanced NSCLC: Updated Overall Survival Analysis of LUX-Lung 7 期刊论文
2017, 卷号: 12, 期号: 1, 页码: S335-S336
作者:  Park, Keunchil;  Tan, Eng Huat;  Zhang, Li;  Hirsh, Vera;  O'Byrne, Ken
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial 期刊论文
2016, 卷号: 17, 期号: 5, 页码: 577-589
作者:  Park, Keunchil;  Tan, Eng-Huat;  O'Byrne, Ken;  Zhang, Li;  Boyer, Michael
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk 期刊论文
2016, 卷号: 150, 期号: 7, 页码: 1633-1645
作者:  Zeng, Chenjie;  Matsuda, Koichi;  Jia, Wei-Hua;  Chang, Jiang;  Kweon, Sun-Seog
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/04
First-line afatinib (A) vs gefitinib (G) for patients (pts) with EGFR mutation positive (EGFRm plus ) NSCLC (LUX-Lung 7): Patient-reported outcomes (PROs) and impact of dose modifications on efficacy and adverse events (AEs). 期刊论文
2016, 卷号: 34, 期号: 15
作者:  Hirsh, Vera;  Yang, James Chih-Hsin;  Tan, Eng-Huat;  O'Byrne, Ken;  Zhang, Li
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04
First-line afatinib (A) vs gefitinib (G) for patients (pts) with EGFR mutation positive (EGFRm plus ) NSCLC (LUX-Lung 7): Patient-reported outcomes (PROs) and impact of dose modifications on efficacy and adverse events (AEs). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Hirsh, Vera;  Yang, James Chih-Hsin;  Tan, Eng-Huat;  O'Byrne, Ken;  Zhang, Li
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04
New loci and coding variants confer risk for age-related macular degeneration in East Asians 期刊论文
Nature Communications, 2015, 卷号: 6, 页码: 6063
作者:  Cheng, Ching-Yu*;  Yamashiro, Kenji;  Chen, Li Jia;  Ahn, Jeeyun;  Huang, Lulin
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/03
New loci and coding variants confer risk for age-related macular degeneration in East Asians 期刊论文
NATURE COMMUNICATIONS, 2015, 卷号: 6
作者:  Cheng, Ching-Yu;  Yamashiro, Kenji;  Chen, Li Jia;  Ahn, Jeeyun;  Huang, Lulin
收藏  |  浏览/下载：20/0  |  提交时间：2019/12/13
New loci and coding variants confer risk for age-related macular degeneration in East Asians 期刊论文
2015, 卷号: 6, 页码: 6063
作者:  Cheng, Ching-Yu;  Yamashiro, Kenji;  Chen, Li Jia;  Ahn, Jeeyun;  Huang, Lulin
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace